
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Financière de Tubize
Market Cap: €8.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€185.60
7D
-3.0%
1Y
18.1%
Hyloris Pharmaceuticals
Market Cap: €125.7m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.43
7D
-1.6%
1Y
-30.1%